Dicyclomine Hydrochloride Tablet
Product Images NDC 0615-8622

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dicyclomine Hydrochloride (NDC 0615-8622). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure Of Dicyclomine Hydrochloride (Dicyclomine Tabs 8622 1)

Structure Of Dicyclomine Hydrochloride (Dicyclomine Tabs 8622 1)
Chemical structure diagram of dicyclomine hydrochloride showing its molecular arrangement with cyclohexane rings, ester linkage, and tertiary amine functional groups.*
FDA Label Image

Principal Display Panel (Dicyclomine Tabs 8622 2)

Principal Display Panel (Dicyclomine Tabs 8622 2)
Label for Dicyclomine Hydrochloride Tablets USP 20 mg with a quantity of 30 tablets. The label indicates the product is manufactured by Rubicon for Advagen and packaged by Vangard Labs in Glasgow, KY. It includes barcode information, storage instructions, and a space for recording receipt dates. The label is marked for institutional use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.